EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomic profiling of Elp1‐deficient trigeminal ganglia reveals disruption of neurotrophic and metabolic pathways in a familial dysautonomia mouse model

Carrie E Leonard, Lauren Clarissa Tang, Beatrix Ueberheide, Lisa A Taneyhill iD

Developmental Dynamics · 10.05.2026

DOI: 10.1002/dvdy.70145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Developmental Dynamics, online erschienen am 10.05.2026. Verfasst von Carrie E Leonard und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal and Avian Sciences, University of Maryland, College Park, Maryland, USA. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Elp1, a subunit of the Elongator complex, is essential for tRNA modification and neuronal development. Mutations in ELP1 underlie familial dysautonomia (FD), a disorder marked by sensory and autonomic neuropathy. While loss of Elp1 disrupts trigeminal ganglion formation and survival, the downstream molecular consequences remain poorly defined.

Results

We performed quantitative proteomic profiling of trigeminal ganglia from Elp1 conditional knockout (CKO) and control embryos at E13.5. Across 5650 detected proteins, 25 were significantly up‐regulated and 26 down‐regulated in Elp1 CKO embryos. EnrichR analysis revealed enrichment of up‐regulated proteins in amino acid transport and tRNA aminoacylation pathways, with links to neuromuscular and neuropathic diseases. Down‐regulated proteins were associated with RNA modification, cholesterol biosynthesis, and synaptic organization. Validation by immunohistochemistry confirmed decreased expression of the neurotrophic receptor Gfra3 and the neuropeptide Galanin, and increased levels of the chromatin regulator Chd1, in Elp1 CKO embryos relative to controls.

Conclusions

These findings demonstrate that Elp1 loss disrupts metabolic, RNA modification, and neurotrophic signaling pathways in the developing trigeminal ganglion. Proteomic analysis thus provides new insight into the molecular consequences of Elp1 deficiency and highlights candidate mechanisms contributing to sensory neuron vulnerability in FD.

Schlagwörter

Stichwörter der Autor:innen

Elp1elongatorfamilial dysautonomiaproteomicstrigeminal ganglion

Autor:innen und Institutionen

  • Department of Animal and Avian Sciences, University of Maryland, College Park, Maryland, USA.
  • Proteomics Laboratory, Division of Advanced Research Technologies, New York University Grossman School of Medicine, New York, New York, USA.
  • Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, New York, USA.
  • Department of Neurology, New York University Langone Health, New York, New York, USA.
  • Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York University, New York, New York, USA.

ORCID-Profile: Lisa A Taneyhill

Förderung

  • NICHD NIH HHS
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development

Zitieren

APA

Leonard, C. E., Tang, L. C., Ueberheide, B., & Taneyhill, L. A. (2026). Proteomic profiling of Elp1‐deficient trigeminal ganglia reveals disruption of neurotrophic and metabolic pathways in a familial dysautonomia mouse model. Developmental Dynamics. https://doi.org/10.1002/dvdy.70145

Vancouver

Leonard CE, Tang LC, Ueberheide B, Taneyhill LA. Proteomic profiling of Elp1‐deficient trigeminal ganglia reveals disruption of neurotrophic and metabolic pathways in a familial dysautonomia mouse model. Developmental Dynamics. 2026. doi:10.1002/dvdy.70145

BibTeX
@article{Leonard2026,
  author = {Leonard, Carrie E and Tang, Lauren Clarissa and Ueberheide, Beatrix and Taneyhill, Lisa A},
  title = {Proteomic profiling of Elp1‐deficient trigeminal ganglia reveals disruption of neurotrophic and metabolic pathways in a familial dysautonomia mouse model},
  journal = {Developmental Dynamics},
  year = {2026},
  doi = {10.1002/dvdy.70145}
}
Kostenlos starten →